SCHOLAR ROCK HOLDING CORPORATION Amortization of Debt Issuance Costs
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Amortization of Debt Issuance Costs of $143.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for the quarter ending 2026-06-30 was $109.00K, a 678.57% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for the quarter ending 2026-03-31 was $34.00K, a 92.41% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for the quarter ending 2025-12-31 was $98.00K, a 108.51% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for the quarter ending 2025-09-30 was -$137.00K, a 292.96% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for fiscal 2025 was $423.00K, a 67.19% increase from fiscal 2024.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for fiscal 2024 was $253.00K, a 7.66% decline from fiscal 2023.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for fiscal 2023 was $274.00K, a 61.94% decline from fiscal 2022.
- SCHOLAR ROCK HOLDING CORPORATION amortization of debt issuance costs for fiscal 2022 was $720.00K, a 114.93% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $143.00K 10-Q · filed 2026-08-06 | $241.00K derived: sum of 3 quarters · filed 2026-08-06 | $104.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-07 | $132.00K derived: sum of 2 quarters · filed 2026-05-07 | -$5.00K derived: sum of 3 quarters · filed 2026-05-07 | $9.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$39.00K derived: sum of 2 quarters · filed 2026-03-03 | -$25.00K derived: sum of 3 quarters · filed 2026-08-06 | $423.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$123.00K derived: sum of 2 quarters · filed 2026-08-06 | $325.00K 10-Q · filed 2025-11-14 | $372.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $462.00K 10-Q · filed 2026-08-06 | $509.00K derived: sum of 3 quarters · filed 2026-08-06 | $580.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $448.00K 10-Q · filed 2026-05-07 | $495.00K derived: sum of 2 quarters · filed 2026-05-07 | $566.00K derived: sum of 3 quarters · filed 2026-05-07 | $624.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $118.00K derived: sum of 2 quarters · filed 2026-03-03 | $176.00K derived: sum of 3 quarters · filed 2026-03-03 | $253.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $129.00K derived: sum of 2 quarters · filed 2025-11-14 | $206.00K 10-Q · filed 2025-11-14 | $265.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $135.00K 10-Q · filed 2025-08-06 | $194.00K derived: sum of 3 quarters · filed 2025-08-06 | $252.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $77.00K 10-Q · filed 2025-05-14 | $136.00K derived: sum of 2 quarters · filed 2025-05-14 | $194.00K derived: sum of 3 quarters · filed 2025-05-14 | $266.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $117.00K derived: sum of 2 quarters · filed 2025-02-27 | $189.00K derived: sum of 3 quarters · filed 2025-02-27 | $274.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $130.00K derived: sum of 2 quarters · filed 2024-11-12 | $215.00K 10-Q · filed 2024-11-12 | $362.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $157.00K 10-Q · filed 2024-08-08 | $304.00K derived: sum of 3 quarters · filed 2024-08-08 | $488.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $85.00K 10-Q · filed 2024-05-07 | $232.00K derived: sum of 2 quarters · filed 2024-05-07 | $416.00K derived: sum of 3 quarters · filed 2024-05-07 | $607.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $331.00K derived: sum of 2 quarters · filed 2024-03-19 | $522.00K derived: sum of 3 quarters · filed 2024-03-19 | $720.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $375.00K derived: sum of 2 quarters · filed 2023-11-07 | $573.00K 10-Q · filed 2023-11-07 | $660.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $389.00K 10-Q · filed 2023-08-09 | $476.00K derived: sum of 3 quarters · filed 2023-08-09 | $557.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $198.00K 10-Q · filed 2023-05-09 | $285.00K derived: sum of 2 quarters · filed 2023-05-09 | $366.00K derived: sum of 3 quarters · filed 2023-05-09 | $450.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $168.00K derived: sum of 2 quarters · filed 2023-03-07 | $252.00K derived: sum of 3 quarters · filed 2023-03-07 | $335.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $165.00K derived: sum of 2 quarters · filed 2022-11-14 | $248.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $167.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $83.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $58.00K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |